ConductScience.org, home

Trial · NCT01096082

Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3

NCT01096082, Phase 2, Phase 3, Completed, Hospital de Clinicas de Porto Alegre

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3. Trials, record NCT01096082. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01096082

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
NCT number
NCT01096082
Status
Completed
Phases
Phase 2, Phase 3
Enrollment
62 participants, actual
Lead sponsor
Hospital de Clinicas de Porto Alegre
Conditions
Spinocerebellar Ataxia Type 3, Machado Joseph Disease
Interventions
Lithium Carbonate, Placebo
First posted
2010-03-30
Last updated
2013-01-30

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPhase 2 - Safety and tolerability of Lithium Carbonate treatment in patients with SCA36 monthsAccording to the Common toxicity criteria manual, version 2.0
PrimaryPhase 3 - Efficacy of Lithium Carbonate treatment in patients with SCA312 monthsApplication of the Neurological Examination Score for SCA 3 (NESSCA)
SecondaryEfficacy of Lithium Carbonate in patients with SCA3 on neurological function, ataxic, depressive and quality of life scores6 and 12 months
Scale for the Assessment and Rating of Ataxia (SARA), 9-Hole Peg Board test, 8m walking time, PATA repetition rate, Click Test, SCA Functional Index (SCAFI), Composite Cerebellar Functional Score (CCFS), Beck Depression Inventory, Barthel Index and WHOQol
SecondaryEffect of Lithium Carbonate treatment in peripheral levels and expression of treatment biomarkers3 and 6 monthsBDNF, NSE, HDAC, GSK-3Beta

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
17535104BACKGROUNDPubMed
24399647DERIVEDPubMed
26297649DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01096082

GET https://conductscience.org/api/trials/v1/NCT01096082/registered